Research Appraisalother

Critical care management of the patient with pharmaceutical poisoning

Intensive Care MedHüser, Christoph, Bethlehem, Carina, Dünser, Martin W et al.1 Dec 2025DOI

Clinical Snapshot

65CEBM
Evidence: Moderateother

PICO Framework

P — PopulationCritically ill patients with pharmaceutical poisoning admitted to intensive care units
I — InterventionEvidence-based critical care management strategies including ABCDE approach, gastrointestinal decontamination, extracorporeal elimination, antidote therapy, and rescue interventions
C — ComparatorStandard supportive care approaches
O — OutcomesPatient recovery, need for targeted interventions, organ support requirements, clinical decision-making guidance

Bottom Line

This comprehensive state-of-the-art review provides intensivists with a practical, structured approach to managing pharmaceutical poisoning in the ICU. The ABCDE framework for initial resuscitation, combined with clear algorithms for gastrointestinal decontamination, extracorporeal elimination, and antidote therapy, offers valuable clinical guidance. While the review lacks systematic methodology, the expert synthesis addresses a significant clinical need, as poisonings account for up to 10% of ICU admissions. The visual algorithms and comprehensive antidote table enhance practical utility. Australian intensivists will find this particularly relevant given the availability of described interventions including ECMO and extracorporeal elimination techniques in major tertiary centers. The structured approach to escalating from supportive care to specific interventions provides a rational framework for clinical decision-making in this complex patient population.

Evidence: Moderate

Key Findings

  • Effect Size: Not applicable - narrative review

  • Primary Outcome: Structured evidence-based approach to pharmaceutical poisoning management in ICU settings

  • Nnt Or Sensitivity: Clinical decision algorithms provided for diagnostic evaluation, ABCDE stabilization, gastrointestinal decontamination, and extracorporeal elimination

  • Confidence Interval: Not provided

Clinical Application

High feasibility with structured algorithms and decision pathways designed for real-world ICU application Highly relevant to Australian ICUs; antidote availability through hospital pharmacy services; ECMO capabilities align with major Australian tertiary centers; guidance compatible with ANZICS guidelines ICU patients with pharmaceutical poisoning, representing up to 10% of ICU admissions

Abstract

Poisonings account for up to 10% of admissions to intensive care units and represent a common yet complex challenge in critical care. While most patients recover with supportive care alone, a significant proportion require targeted interventions and advanced organ support. This state-of-the-art review provides a practical, evidence-based guide to manage pharmaceutical poisoning in the intensive care unit, with emphasis on real-world applicability for intensivists. It highlights toxicant-specific considerations for early resuscitation, structured by the ABCDE approach. Essential principles of the diagnostic workup are also summarized. In addition, the review offers actionable guidance on when and how to escalate care, moving from supportive measures to specific interventions including gastrointestinal decontamination, extracorporeal toxicant elimination, antidote therapy, and rescue strategies such as intravenous lipid emulsion and extracorporeal membrane oxygenation. Key algorithms and decision pathways-such as the diagnostic evaluation, ABCDE-based stabilization, gastrointestinal decontamination, and extracorporeal elimination approaches-are presented with visually structured figures. A comprehensive table provides an overview of the most relevant antidotes used in critical care, including indications and dosing.

References

  1. 1.Hüser, C., Bethlehem, C., Dünser, M. W., Genbrugge, C., Ghannoum, M., Hoegberg, L. C. G., Van der Linden, L., Roedl, K., Sabbe, M., Sikma, M. A., Vodovar, D., & Mégarbane, B. (2025). Critical care management of the patient with pharmaceutical poisoning. Intensive Care Medicine. https://doi.org/10.1001/jamanetworkopen.2023.27739
Share:XLinkedIn

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service